Home › Funds › Foresite Capital Management V, LLC › PHVS
Foresite Capital Management V, LLC position in PHVS
PHARVARIS N V · Health Care
Foresite Capital Management V, LLC reported holding 664,142 shares of PHVS (PHARVARIS N V) in its Q3 2026 13F filing — a position valued at US$21.1M, representing 7.29% of its reported portfolio and ranking #6 among its reported holdings. Foresite Capital Management V, LLC has disclosed PHVS holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Foresite Capital Management V, LLC's PHVS position evolved
Foresite Capital Management V, LLC first disclosed a stake in PHVS in Q3 2023 at 33,142 shares (US$692K). The position peaked in Q2 2026 at 664,142 shares, worth US$23.0M. Across 4 filings, Foresite Capital Management V, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 664,142 shares valued at US$21.1M. Notable position changes include a 242% increase in Q2 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 33.14K | $691.67K | New |
| Q1 2026 | 194.12K | $5.48M | New |
| Q2 2026 | 664.14K | $22.97M | Add |
| Q3 2026 | 664.14K | $21.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PHVS and 13F data
PHVS (PHARVARIS N V) is a Health Care company. 47 other funds we track also report a position in PHVS — the largest reported positions include Foresite Capital Management IV, LLC (US$151.6M), venBio Partners LLC (US$141.4M), EQT Fund Management S.a r.l. (US$108.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PHVS
- Foresite Capital Management IV, LLC 4.78M sh · $151.58M · Q3 2026
- venBio Partners LLC 4.46M sh · $141.44M · Q3 2026
- EQT Fund Management S.a r.l. 3.42M sh · $108.63M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.59M sh · $82.15M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 2.48M sh · $76.92M · Q3 2026
- GENERAL ATLANTIC, L.P. 1.65M sh · $52.39M · Q3 2026
- Saturn V Capital Management LP 1.39M sh · $44.22M · Q3 2026
- Novo Holdings A/S 1.02M sh · $32.34M · Q3 2026
- Jones Hill Capital LP 987.64K sh · $31.33M · Q3 2026
- TCG Crossover Management, LLC 947.54K sh · $30.06M · Q3 2026
- Commodore Capital LP 925.00K sh · $29.34M · Q3 2026
- Tetragon Partners GP Ltd 838.25K sh · $26.59M · Q3 2026
More on Foresite Capital Management V, LLC
FAQ
How long has Foresite Capital Management V, LLC held PHVS?
Foresite Capital Management V, LLC has disclosed PHVS holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is Foresite Capital Management V, LLC's current position in PHVS?
As of Q3 2026, Foresite Capital Management V, LLC holds 664.14K shares of PHVS (PHARVARIS N V), valued at $21.07M, representing 7.29% of its reported portfolio and ranking #6.
Has Foresite Capital Management V, LLC been buying or selling PHVS?
In the latest 13F filing (Q3 2026), Foresite Capital Management V, LLC held unchanged its position in PHVS. The position peaked in Q2 2026 at 664.14K shares.
Which other funds hold PHVS?
Other major institutional holders of PHVS include Foresite Capital Management IV, LLC, venBio Partners LLC, EQT Fund Management S.a r.l., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.